Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Please note, schedule is subject to change. Please check onsite for changes/additions.
2Morrow
2Morrow
2Morrow offers a Digital Therapeutics platform addressing smoking, weight, stress and chronic pain. 2Morrow’s Behavior Change platform engages up to 5X more users or reduces treatment costs up to 75%. Their Third Wave approach was developed with the Fred Hutchinson Cancer Research Center in over 6 clinical trials and $10M of R&D.
Acarix AB
Acarix AB
Acarix is a Swedish/Danish commercial stage medical device company specializing in non-invasive, acoustic rule-out of Coronary Artery Disease. The Acarix CADScor(R)System combines acoustic detection of turbulent arterial flow and myocardial movement with advanced algorithms in a handheld device to provide a patient specific CAD-Score in less than 10 minutes.
Adan Medical Innovation
Adan Medical Innovation
Adan is focused on the management of anaphylaxis. Their lead product is an APPhylaxis, a combination of a smartcase and corresponding app for managing epinephrine autoinjectors, they completed in 2017 a pivotal clinical study, and are preparing commercial launch for 2018 in Europe. Their pipeline includes a smart box for public spaces.
Advanced Bifurcation Systems
Advanced Bifurcation Systems
ABS's platform based technology can avoid coronary artery bypass grafting procedures for patients with bifurcation disease. ABS’s patented technology covers design of main and side branch stents and the methodology of assembly which provides complete coverage for all lesions regardless of branch angles, size, plaque burden and location.
Allergia, Inc.
Allergia, Inc.
Allergia has successfully designed, patented, and tested a home-use medical device that uses phototherapeutics to suppress the symptoms of seasonal allergenic rhinitis (hay fever), and which has the potential to disrupt the $7.6B nasal allergy market.
AMRA (AMRA Medical Inc.)
AMRA (AMRA Medical Inc.)
AMRA automatically translates images from a 6-minute whole body MRI into precise fat & muscle measurements, thus improving patient selection and early detection of efficacy. AMRA is involved in research across the metabolic and musculoskeletal fields, with the aim to redefine obesity and metabolic risk using a personalised medicine approach.
Arivale Inc.
Arivale Inc.
Arivale uses innovative science, personalized data, and tailored coaching to deliver prioritized recommendations that help individuals optimize wellness and avoid disease. With its de-identified dataset, Arivale is successfully conducting unprecedented multi-omic research into human health, which has the potential to transform clinical trials and accelerate diagnostic, therapeutic and prevention strategies.
Atentiv
Atentiv
A behavioral healthcare company serving providers, health plans, and employers with evidence-based, differentiated cognitive therapeutics, providing an integrated real-time behavioral health service and coaching platform, beginning with attention and inhibition control skills.
BAROnova, Inc.
BAROnova, Inc.
BAROnova has developed a unique non-surgical gastric/duodenal medical device for obesity reduction. Based upon its design and pilot clinical results, the BAROnova device is expected to deliver at least 2-3x the weight-loss treatment efficacy of alternate non-surgical devices . PMA Pivotal trial results will be available late Q1, 2018.
Bayer Grants4Apps
BC Platforms
BC Platforms
BC Platforms provides powerful genomic data management and analysis solutions as well as access to a global research network. Their high performing genomic data management platform enables flexible data integration, secure browsing, analysis and interpretation of molecular and clinical information, and collaborative research.
Big Health Inc.
Big Health Inc.
As the world’s first digital medicine company, Big Health automates behavioral medicine programs, thereby making them scalable, accessible, and consistent. Their first product, Sleepio, is clinically proven to help overcome poor sleep using Cognitive Behavioral Therapy techniques. They are also expanding the product offering to address broader mental health.
Biofourmis
Biofourmis
Biofourmis is a fast-growing global digital health startup that is reinventing remote patient monitoring to bring this extremely demanding goal within reach. By harnessing the power of artificial intelligence, Biofourmis is advancing the practice of medicine by detecting personalized patterns predictive of patient’s health deterioration.
BioFuse Medical Technologies, Inc.
BioFuse Medical Technologies, Inc.
The BioFusion™ BioPolar RF Generator is a disruptive technology that allows surgeons to close wounds without sutures or staples. This BioFuse patented and FDA cleared energy algorithm focuses on maintaining the fluidity and viability of tissue creating a fusion stronger and more rapidly than sutures or staples.
BioSig Technologies, Inc.
BioSig Technologies, Inc.
BioSig Technologies, Inc. is a medical device company that is developing a proprietary technology platform aimed at the rapidly growing $4B+ electrophysiology (EP) marketplace.
BioSymetrics Inc.
BioSymetrics Inc.
BioSymetrics is a biomedical AI (artificial intelligence) company that has built Machine Learning solutions to optimize innovation in life sciences and healthcare. Their technology platform, Augusta™, performs advanced data pre-processing and integrated predictive analytics on big data and complex datasets, in combinations--and works on raw data (deployable anywhere, scaleable architecture).
Biovotion LLC
Biovotion LLC
Biovotion is a leading wearable physiology monitoring company and provides integrated solutions with connected hardware, value-added data analytics and services. Designed with the consumer in mind and medical quality at heart, the platform combines state of the art cybersecurity and GDPR compliance – medical-grade, easy-to-use and 24/7.
BlueJay Mobile Health, Inc
BlueJay Mobile Health, Inc
BlueJay Mobile Health provides a comprehensive solution for healthcare providers to engage patients and improve patient compliance and outcomes. They have developed a unique AI and cloud based patient engagement mobile platforms called “BlueJay Engage”, serving healthcare providers and their patients during rehabilitation.
Body Vision Medical
Body Vision Medical
Medical device company, offering FDA cleared solution to address the unmet clinical need of diagnostics and treatment of lung cancer. Its efficiency proven in 220+ patients with 10 leading U.S. hospitals. Includes software, hardware and disposable tools for real time visualization, guidance and access of lung nodules in a minimally-invasive way.
Calcivis Ltd
Calcivis Ltd
CALCIVIS has developed he world’s first biotechnology-based dental imaging system. For the first time, it allows live visualisation of active tooth demineralisation, enabling dentists to practice and monetise preventive dentistry. The PMA was filed with FDA in October and we soft launch the product in the UK in Jan '18.
Cognoa
Cognoa
Cognoa is an AI-based digital precision platform for behavioral health. The company has completed multiple clinical studies validating the performance of its AI-based diagnostic assessments and is working with clinical researchers and the FDA to develop the first diagnostic devices for diagnosing autism and other behavioral health indications.
Covanos, Inc.
Covanos, Inc.
Covanos: An early stage company, addressing multiple billion dollar market opportunities, with a clinically validated suite of proprietary digital software products based on advanced computational fluid dynamics that enable real-time, point-of-care, clinically relevant diagnosis of both the anatomy and physiology of obstructive vascular disease in a single, non-invasive imaging test.
Dthera Sciences
Dthera Sciences
Dthera Sciences is a publicly-traded Digital Therapeutics company based in San Diego that is working to improve Quality of Life (QoL) and reduce anxiety in patients with Alzheimer's and Dementia. The company has developed a non-pharmaceutical quality of life therapy for Alzheimer's and Dementia patients.
Dymicron
Dymicron
Dymicron is a clinical stage company focused on degenerative disc disease. Its lead product, the Triadyme-C is a cervical total disc replacement device approved for sale in Europe. The Triadyme-C’s design mimics natural motion superior to other devices and is made from polycrystalline diamond and thus experiences minimal wear.
Emovi, Inc.
Emovi, Inc.
KneeKG is a personalized knee assessment device with proven clinical benefits. For the millions of annual knee consultations worldwide (+15M in the United States alone), Emovi's vision is to transform the complete knee episode of care, making it more efficient with better outcomes at lower costs.
Endomagnetics Limited
Endomagnetics Limited
Endomag is a rapidly growing medtech headquartered in Cambridge, England. It offers a unique, minimally-invasive surgical guidance platform to facilitate tissue localization in surgical oncology. Through its partnerships with Leica Biosystems and Sysmex Europe, it is radically improving the standard of care in breast cancer surgery.
FBC Device ApS
FBC Device ApS
FBC Device develops spinal interbody fusion implants. Its unique personalized lordosis concept provides better clinical outcomes and lower inventory costs. The company seeks to enter the US market by partnering with major industry partner. A 510(k) application is under review at the FDA for a new lumbar implant. Cervical implant under development.
Fitscript LLC
Fitscript LLC
A patented solution for reducing, reversing, and controlling diabetes by providing live and interactive multi media exercise content and solutions based on real time glucose levels and other diabetes metrics. GlucoseZone is the future of diabetes management and direct-to-consumer digital health solutions.
GAIA AG
GAIA AG
GAIA is the global leader in R&D for RCT-proven, digital therapeutics. Our mission: Developing therapeutic software that offers physicians, therapists, payers and patients the same effect sizes, similar safety profiles, and equal levels of convenience as found in well-developed pharmaceutical solutions.
gel-e, Inc
gel-e, Inc
gel-e Inc., is a clinical-stage medical device company that is developing a novel line of hemostatic and wound treatment products. gel-e combines the use of safe, inert ingredients with proprietary chemistry that can be designed for use across a broad spectrum of clinical applications, including vascular closure and during surgery.
Genetesis LLC
Genetesis LLC
Genetesis is a clinical stage medical device company that has developed CardioFlux, a biomagnetic imaging device that can passively detect and rapidly rule out coronary artery disease in patients with chest pain.
Genome.One
Genome.One
Genome.One provides a portfolio of services and tools to enable precision healthcare. We provide clinically-accredited testing services for diagnosis of rare and inherited disease and for predisposition to disease. Genome.One is developing a clinical-decision platform to enable contextually relevant interpretation of the genome at point-of-care.
Greenbone Ortho Srl.
Greenbone Ortho Srl.
GreenBone is the strongest bone regenerative material for large scale damage in non-loaded and load-bearing bones and in the spine. Complete bone critical defect regeneration has been achieved in sheep. Manufacturing scale up has been completed. Clinical study in patients with severe bone defects in load-bearing and non-loaded bones is under preparation. Seed round USD 3.5M 2015. Round A USD 9.5M 2Q17.
HealthBeacon Limited
HealthBeacon Limited
World's first connected sharps home medical disposal bin, providing a holistic support platform for biopharmaceutical home-injecting patients. Cloud platform provides patients customized injections schedule reminders, personal adherence scores from a consumer-friendly waste device for used injections. Provides healthcare professionals, patient, and practice reports to integrate with improved standards of care.
Healthimation LLC
Healthimation LLC
Healthimation is a marriage between the leading pre-diabetes and weight management program from the Joslin Diabetes Center and a creative studio of former animators from the entertainment industry to create a virtual companion 3D Pixar-like avatar "Lena" which on a smart phone leads the participants through the 12 week program.
HeartSciences, Inc
HeartSciences, Inc
MyoVista is a new-technology, high-sensitivity ECG/EKG. Applying artificial intelligence to patented continuous wavelet transform measures to transform the clinical efficacy of an ECG and create the world’s best tool to (finally) enable low-cost, highly effective early diagnosis of heart disease. Device plus consumables business model, fully commercialized, and in revenue.
HOYA
HOYA
IDbyDNA, Inc.
IDbyDNA, Inc.
IDbyDNA is an early commercial phase company focused on utilizing metagenomics for infectious disease diagnostics. Based on their core DNA search technology, Taxonomer, IDbyDNA offers a complete sample-to-report solution enabling NGS-based infectious disease testing. Their first diagnostic testing product, Explify™ Respiratory is available nation-wide for clinical use in diagnosing pneumonia.
Inmedix, Inc.
Inmedix, Inc.
Inmedix is defining Immuno-autonomics - the interface between the immune system and stress. Its ANS Neuroscan diagnostic predicted biologic outcome in rheumatoid arthritis with 90% sensitivity/ 95% specificity. ANS mitigation increased biologic remission in RA by 200%. A 2017 health economics study projects $25B savings for payers due to Inmedix.
Interface Biologics, Inc
Interface Biologics, Inc
Interface Biologics, Inc. (IBI) is a commercial stage company with core strengths in applied chemistry and material science. IBI’s technology platforms include (i) surface modification additives proven to inhibit device mediated thrombus formation and (ii) controlled local drug delivery technologies for both combination products and stand-alone pharmaceutical applications.
Iota Biosciences, Inc.
Iota Biosciences, Inc.
Pre-clinical stage company seeking Series A funding. Iota's proprietary dust platform is designed to build vanishingly small implantables with bi-directional communications that can go deep in the human body. Initial applications include using the platform in physiological monitoring and neural interfaces. Also, seeking partnering opportunities with healthcare and technology companies.
Jupiter Diagnostics Ltd.
Jupiter Diagnostics Ltd.
Jupiter Diagnostics offers a simpler way to obtain accurate blood tests enabling clinicians to make faster decisions. Its compact reader can replace the lab, delivering results for multiple tests in 10 minutes from a prick of blood. Its first tests are for IVF and OBGYN clinics.
Lantern Pharma
Lantern Pharma
Lantern Pharma Inc harnesses proprietary genomics & AI tech platform to identify patient subgroups that respond best to new drug therapeutics and bring them to the market in a timely and cost sensitive manner. Lantern is using this approach for 3 clinical phase drugs. 1 successfully partnered. Looking for partners
Liberate Medical LLC
Liberate Medical LLC
Liberate Medical is developing therapeutic electrical muscle stimulation technology to assist breathing in patients with pulmonary disorders. Two products are under development: the VentFree stimulator is designed to reduce mechanical ventilation weaning time, while the SecondBreath stimulator is designed to immediately reduce shortness of breath in patients with COPD.
Life365, Inc.
Life365, Inc.
Life365 is a seed stage company with a software platform of curated "best in class" digital health solutions, that integrates and identifies the “best fit” solutions for health systems to cost effectively gather data from large patient populations at home to improve outcomes & reduce costs.
LLTECH
LLTECH
LLTech has developed real-time cancer diagnosis using biopsies. LLTech allows decision making in the surgical and radiology suites by identifying cells and tumors in real-time. This allows up to 30% productivity (e.g. more revenues for customers with faster margins assessment) and 50% savings on Operating Room costs.
Lumendi Ltd
Lumendi Ltd
Lumendi, a commercial stage company, develops next-generation endoscopic tools that make complex gastrointestinal interventions safer and less expensive. Its endolumenal surgical platform increases the capabilities of current endoscopes, allowing more procedures to be done entirely via the lumen of the colon instead of open or laparoscopic procedures.
LumiThera, Inc.
LumiThera, Inc.
LumiThera, Inc. is a medical device company commercializing a multi-wavelength instrument for the ophthalmologist’s office that improves vision and slows the progression of vision loss in patients with degenerative eye disease. The Company’s focus to date has been on the treatment of patients with dry age-related macular degeneration (AMD).
Lumo Bodytech
Lumo Bodytech
Lumo Bodytech is a biomechanics company that combines wearable sensors, data, and machine learning to improve human movement for better health and pain relief. Its consumer products are built on the Lumo MotionScience Platform which is also used by healthcare partners to co-brand or build entirely new products.
Medable
Medable
Medable is transforming healthcare by enabling patient generated data to drive healthcare delivery, clinical research, and personalized and predictive medicine. The Medable platform is currently licensed by over 15 leading hospitals and 4 biopharma to enable connected clinical trials and remote clinical care.
Medigram Inc.
Medigram Inc.
Medigram Enterprise is a secure real time communication and events processing platform for mobile health. It is designed to take in information integrated from medical devices. Medigram will automate and streamline everything in a conversational automation solution. Medigram offers the only connectivity guarantee in the industry. Currently in beta.
MedImmune
MedImmune
Mensia Technologies SA
Mensia Technologies SA
Mensia Technologies develops non-invasive medical devices for the care of neuro-psychiatric conditions directly in the home of patients. Its first target is Attention Deficit Disorder (ADHD), for which we have developed Mensia Koala, a device now CE Marked. Other potential targets include back pain and Mild Cognitive Impairment.
Meru Health Inc.
Meru Health Inc.
Meru Health is an online specialty clinic for depression (& burnout) treatment. Meru’s 8-week treatment program combines psychological treatment modules, patient’s personal data (biometric, behavioural, self-report) and a personal therapists, to individualize treatment, making it more effective than other currently available solutions.
MFB Fertility, Inc.
MFB Fertility, Inc.
This company is focused on developing novel in vitro diagnostic medical devices used for monitoring reproductive hormones in women. Its urine progesterone test was brought to market in February 2017. Its second product is in the pre-clinical stage of development.
NeoLight
NeoLight
NeoLight is a med-tech company developing empathy-driven and best-in-class tech for the newborn care market. It's flagship product - the Skylife phototherapy device for treating infant jaundice is pending FDA clearance in Oct 2018. They have also filed patents for a point-of-care diagnostic strip for jaundice very recently.
NeuroMetrix, Inc.
NeuroMetrix, Inc.
NeuroMetrix is a commercial stage, innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform.
Nexstim Plc
Nexstim Plc
Nexstim is a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic (NBT® system) and diagnostic (NBS system) applications. Nexstim's NBS system is the only FDA cleared and CE marked system based on navigated Transcranial Magnetic Stimulation (nTMS).
Oventus Medical Ltd
Oventus Medical Ltd
Oventus is a medical device company in the sleep apnea sector with regulatory approval, reimbursement, and distribution in place for their core technology which is a patented 3D printed airway, significantly improving treatment outcomes. Clinical evidence and IP protection delivers a significant competitive advantage in this multi-billion dollar market segment.
Owkin, Inc.
Owkin, Inc.
OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development. OWKIN’s proprietary platform, OWKIN Plus uses machine learning-based modeling to analyze molecular, imaging libraries and patient datasets to uncover complex biomarker patterns that cause disease.
Pear Therapeutics, Inc.
Pear Therapeutics, Inc.
PillTracker, Ltd
PillTracker, Ltd
PillTracker is the first medication adherence platform that will be cGMP compliant with drug manufacturing/packaging, and user friendly to patients. The secret is a patented, printed electronic layer which allows any packaged drug to be read by our cellular enabled Android device without embedded sensors. Product Demo available here: https://www.youtube.com/watch?v=ZdrCqJGXmY0
Pneuma Respiratory, Inc
Pneuma Respiratory, Inc
Pneuma is a clinical stage company focused on respiratory diseases. Pneuma’s novel drug delivery technology is anticipated to enter Phase II/III trials as a 505b2 submission with a rescue indication for asthma and COPD. Pneuma has four additional respiratory assets and three large molecule compounds in development.
Portola Capital Partners
PrecisionProfile, Inc.
PrecisionProfile, Inc.
PrecisionProfile dramatically accelerates the research and adoption of Precision Oncology. The company provides oncologists with a comprehensive, actionable view of genomic profiles, diagnostic reports, treatment guidelines, and drug trials. For researchers, PrecisionProfile provides analysis insights to large patient cohorts to enable new drug discovery and targeting of clinical trials.
ProLung Inc.
ProLung Inc.
ProLung is a medical technology company specializing in predictive analytic lung cancer risk testing. The rapid, non-invasive, and radiation-free ProLung Test™ was developed to rapidly assess the risk of malignancy in lung nodules found in the chest.
QalibreMD, Inc.
QalibreMD, Inc.
QalibreMD’s strategy is to transform medical imaging from a simple diagnosis of a lesion, to an exact diagnosis of what disease is present in a fraction of what a current AMRI scan takes. We have 4 MRI standards and have sold our products to the top research hospitals throughout the world.
Qualcomm Life
Qualcomm Life
Qventus, Inc.
Qventus, Inc.
At Qventus, their mission is to simplify how healthcare operates, so that hospitals and caregivers can focus on patient care. The company uses artificial intelligence and machine learning to automate operational decisions across the hospital, including emergency departments, pharmacies, perioperative areas, patient safety programs, inpatient, and outpatient care.
Revon Systems, Inc.
Revon Systems, Inc.
REVON is a clinical stage digital drug development company in Phase II trials. The company develops digital therapeutics called Smart Symptom Trackers (SSTs) trained by machine learning to reduce the severity of chronic disease symptoms and unnecessary hospitalizations by helping patients seek care for initial symptoms of their disease.
RFPi, Inc
RFPi, Inc
RFPi is commercializing an imaging technology that enables health care providers to visualize blood flow and perfusion. The technology is non-contact and non-invasive. The first application for the surgical suite is currently under review by the FDA with approval anticipated in Q1 2018.
Savonix, Inc.
Savonix, Inc.
The Savonix Digital Cognitive Assessment Platform provides a simple and cost-effective way to gauge cognitive function. Savonix delivers the world’s first mobile, evidence-based assessment of cognitive and emotional function. The digital screen is a 30-minute assessment accessed from any iOS or Android device, available via a license from healthcare organizations.
Sense Diagnostics, LLC
Sense Diagnostics, LLC
Three million Americans suffer severe brain injuries each year. Delays in getting stroke and TBI patients to the right hospital and monitoring them once there contribute to the death or disability for far too many patients. Sense Diagnostic's scanner uses radio waves to reduce the time it takes to start treatment.
SentiAR, Inc.
SentiAR, Inc.
SentiAR is a venture-backed clinical stage digital health company developing the first intraprocedural augmented reality platform for interventional procedures. Through the Microsoft HoloLens, the initial application will provide safer, faster catheter ablations treating cardiac arrhythmia. FDA 510(k) submission as a Class 2 device is expected in mid-2018.
SMART Brain Aging, Inc.
SMART Brain Aging, Inc.
SMART Brain Aging, Inc. aims to help mitigate the cognitive and functional decline associated with early stage dementia. The company has two research-backed products: SMART Memory Program (a Medicare-reimbursable based paper-and-pencil product) and SMART Brain U, an on-line SaaS based platform. Please see www.smartbrainaging.com for more information.
Sober Grid
Sober Grid
Sober Grid is a digital health app for substance abuse disorder that allows for medication adherence, monitoring, and peer to peer support network. The platform uses artificial intelligence to predict relapses and then deliver digital interventions to lower relapse rates. The company is seeking investment, partnerships and white label opportunities.
Somatix inc.
Somatix inc.
Somatix’s lead product – SmokeBeat ™ a smoking cessation monitoring solution that works with wearables - is a market ready product that been is being tested by leading academic medical centers and clinics in US, Canada, France, Israel and more. The 2nd product SafeBeing™ an elderly care assistance due Q1/18
Two Pore Guys, Inc.
Two Pore Guys, Inc.
2PG's handheld Molecular Meter (MoM) detects and quantitates both DNA/RNA and analyte targets in a rapid, inexpensive form factor that works like a glucose meter. Anyone can test for anything, anywhere.
TymCure
TymCure
TymCure Ltd. is a private Israeli company founded in 2014 specializing in ENT devices that treat eardrum perforations. TymCure is raising USD $8M to improve the device, finalized the membrane, enter a clinical trial, and submit a CE-mark approval before obtaining FDA clearance next year.
Univfy, Inc
Univfy, Inc
Univfy is an early stage company with a commercialized SaaS platform that uses proprietary technology combining machine learning, AI, and fintech to support IVF centers (its client) to offer personalized predicted probabilities of IVF success and financial packages that make IVF treatment affordable to patients. Series A funded. Scaling.
ViewsIQ Inc.
ViewsIQ Inc.
ViewsIQ provides imaging software to digitize patient samples microscopically for pathologists, the unsung heroes of laboratory medicine responsible for 70% medical decisions. Without changing a laboratory's existing workflow and equipment, ViewsIQ's digital pathology solutions allow U.S. diagnostic laboratories to earn back $2B/year in reimbursement revenue lost in travel and procedural waiting times.
Welkin Health
Welkin Health
Welkin’s configurable case management platform integrates data and multi-channel communication tools to streamline complex workflow for their partners, creating a better patient experience and delivery of care. Companies can then focus on the patient experience and clinical pathways rather than productivity tools.
WellDoc, Inc.
WellDoc, Inc.
WellDoc® created an FDA-cleared, proven digital therapeutic, BlueStar®, that provides real-time and timely personalized coaching and support, as well as diabetes educational tools that are actionable and individualized for adults living with type 2 diabetes. Our clinical evidence shows a 1.7 to 2.0 point mean A1C reduction.